Manufacturer IP Strategy Under PBM Pressure: Evergreening, Lifecycle Management, and Formulary Defense The Evergreening Toolkit and Its Formulary Interaction Pharmaceutical manufacturers pursue lifecycle management strategies commonly called evergreening to extend the effective commercial exclusivity of branded drugs beyond the expiration of the primary compound patent
No, Lexapro and Xanax are different medications
The median duration of constipation in clinical trials was 47 days, so its worth being proactive
Food triggers that often make sulfur burps worse This is the part that can feel frustrating: what sets off sulfur burps for one person might be totally fine for another
Individuals with certain alleles at these loci may require higher doses or dual-compound therapy to achieve the same appetite suppression as others
Incremental Increases: Following the initial phase, the dose is gradually increased every four weeks, under the guidance of your healthcare provider (e.g., to 0.5 mg, then 1.0 mg, and potentially up to 2.4 mg for weight management, as seen with Wegovy, or 2.0 mg for type 2 diabetes, as with Ozempic)
